·   Log in

Archive for November, 2009

Reboxetin (Edronax, Vestra) has little benefit in depression treatment : IQWiG

Thursday, November 26, 2009 20:39

Reboxetin has no significant benefit in controlling depression, according to the final report of the Institute for Quality and Efficiency in Health Care (IQWiG).

This was posted under category: health  |  Read Full Story  |  1 Comment

Ranbaxy may spin $200 million on 180-day exclusive sales of valaciclovir generic pills: Analysts

Thursday, November 26, 2009 19:37

Ranbaxy has launched generic version of the blockbuster anti-viral valaciclovir pills in the US.

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments

Dimedon (latrepirdine) for Alzheimer’s could be a breakthrough drug: Study

Thursday, November 26, 2009 19:35

Dimebon shown to protect brain cells from damage and enhance brain survival

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with:

Sun Pharma’s generic atomoxetine pills (Strattera) wins tentative approval from US FDA

Thursday, November 26, 2009 18:20

Indian generic major Sun Pharma's generic atomoxetine pills have won tentative approval from US FDA.

This was posted under category: Industry  |  Read Full Story  |  0 Comments

South Korea drops plan to buy 3 million doses Glaxo’s H1N1 swine flu vaccine: Report

Wednesday, November 25, 2009 23:18

South Korea no longer plans to buy GlaxoSmithKline Plc’s H1n1 swine flu vaccine, Pandemrix, reports said quoting health ministry officials.

This was posted under category: health  |  Read Full Story  |  0 Comments

Biotherapeutics to propel contract manufacturing in India and China : Report

Wednesday, November 25, 2009 22:14

CMOs market to touch $33.7bn by 2014 from the current $22.2bn

This was posted under category: Biotech, Featured  |  Read Full Story  |  0 Comments

Shire to supply velaglucerase alfa free for Gaucher disease patients, initially

Wednesday, November 25, 2009 21:23

Velaglucerase alfa, an enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease, may hit the market soon.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments

Avastin for colorectal cancer rejected again in UK; Erbitux stands to gain

Wednesday, November 25, 2009 21:12

Avastin, the much-hyped block-buster anti-cancer therapy from Roche has been rejected by as treatment against colorectal cancer.

This was posted under category: Pharma  |  Read Full Story  |  0 Comments

Hepatitis C drug Albinterferon alfa-2b nearing FDA approval in US: Human Genome Sciences

Wednesday, November 25, 2009 18:42

Human Genome Sciences, Inc is seeking approval for albinterferon alfa-2b (Zalbin)  for the treatment of chronic hepatitis C.

This was posted under category: health  |  Read Full Story  |  0 Comments

ARCA’s heart failure treatment Gencaro (bucindolol) may get faster US FDA approval

Wednesday, November 25, 2009 18:37

Gencaro (bucindolol hydrochloride) for the treatment of patients with chronic heart failure by ARCA bioharma Inc has been granted fast track designation by US FDA.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments